Introduction
with high density lipoprotein (3) and a defective ability to activate lecithin: cholesterol acyltransferase (4) . Another variant, (Pro 143 --> Arg), in which prolineApolipoprotein A-I is the major protein constituent 143 is substituted by argmine is a poorer activator of tern contains 243 ammo acid residues and its primary , . ,.
,_, 11 r ι. · ι . , /<1N _, · · ι ι_ · ι · * lecithin : cholesterol acyltransferase than is normal structure is known (1 Ι --Λ Τ r ΤΤ-ΓΝΤ *· ι j We have previously reported that apolipoprotem A-I of HDL particles, and -v · , · · j-i. -undergoes a non-enzymatic glycation in diabetic sub-2) activation of the enzyme lecithin : cholesterol acyl-jects (6) and that this modification alters its selftransferase (2), which is responsible for the esterifi-association and lipid binding properties in vitro (7) . cation of cholesterol in human plasma.
More recently, we have shown that the non-enzymatic Several genetically determined variants of apolipo-g)y c ation of apolipoprotein A-I diminishes its assoprotein A-I have been described in the human pop-°i atl°n Wlth hlgh density h P°P rotein in V1VO ( 8 )· ulation and the effects of these mutations on the In this report we document that glycated apolipoproapolipoprotein functions have been tested. The vari-tein A-I purified from the plasma of diabetic subjects ant (Lysioy-o) in which lysine at residue 107 is deleted is deficient in its ability to activate lecithin: cholesterol have been proved to have a decreased association acyltransferase in vitro.
Materials and Methods
Purification of apolipoprotein A-I and glycated apolipoprotein A-I High density lipoprotein was isolated from pooled fresh nondiabetic and diabetic human plasma by sequential ultracentrifugation in the density range 1.063-1.20 kg/1 (9) . HDL was delimitated with ether: ethanol (3 + 1 by vol.) at 4 °C and the apolipoproteins were fractionated on a Sephadex G 150 column (10) . Giycated apolipoprotein A-I was purified from the apolipoprotein A-I of diabetic patients by affinity chromatography in aminophenylboronic acid (Affi Gel 601) (7) . All apolipoprotein preparations yielded a single band on SDS-polyacrylamide electrophoresis. Absence of other posttranslational modifications of apolipoprotein A-I and glycated apolipoprotein A-I was confirmed by amino acid analysis. Glycated apolipoprotein A-I contains 1-2 glucose molecules per apolipoprotein A-I molecule.
Purification of lecithin : cholesterol acyltransferase
Lecithin : 9holesterol acyltransferase was prepared as described previously (11) . Briefly, fresh human plasma was ultracentrifuged at d = 1.23 kg/1 for 48 h at 45000 min" 1 in a Ti 50 rotor at 10 °C. The clear middle zone between the floating lipoproteins and the sedimenting plasma proteins was aspirated, dialysed and chromatographed on a column containing DEAE cellulose. Fractions containing lecithin : cholesterol acyltransferase activity were precipitated with ammonium sulphate and butanol and chromatographed on a Sephadex G 100 column. The purity of this enzyme fraction was assessed by polyacrylamide gel electrophoresis in 10 g/1 sodium dodecyl sulphate. Assay of the lecithin : cholesterol acyltransferaseactivating property of apolipoprotein A-I and glycated apolipoprotein A-I Eighty μΐ of substrate, 20 μΐ of 2-mercaptoethanol, ΙΟμΙ of human serum albumin (50 g/1) and 140 μΐ of Tris-HCl 10 mmol/1, pH 7.4 were preincubated in a shaking water bath at 37 °C for 60 min. The reaction was initiated by addition of 50 μΐ of lecithin : cholesterol acyltransferase (0.30 g/1) and continued for 30 min under the same conditions. The reaction was stopped by the addition of 0.5 ml of methanol. The methanol-containing incubation mixture was extrated with 1 ml of hexane. Cholesteryl esters were separated from free cholesterol by silica gel column chromatography (elution with diethyl ether : hexane (1 + 6, by vol.).
The labelled cholesteryl esters were cqllected, mixed with 5 nil of scintillation cocktail and the radioactivity was measured in a liquid scintillation analyser, Packard 1600 TR. Blanks without enzyme were run in parallel. All the experiments were performed in duplicate. The precision of the method was 9.6%, as expressed by the coefficient of variation.
The activity of lecithin : cholesterol acyltransferase was calculated from the specific radioactivity of cholesterol and expressed as nmol of cholesterol ester formed per hour. Linear regression analysis was used to obtain the apparent (app) kinetic constants: app. V max , app. K m > and app. V max /app. K m .
Results
Apolipoprotein A^I and glycated apolipoprotein A-I were individually tested for their ability to activate lecithin : cholesterol acyltransferase in vitro.
Concentration-dependent, saturable activation of the enzyme reaction was observed for both the apolipoprotein A-I and the glycated apolipoprotein A-I. The results of the activator saturation experiments were analysed by the double reciprocal plot ace. to Lineweaver-Burk using normal Michaelis-Menten kinetics.
As shown in figure 1 , the activation of esterification by glycated apolipoprotein A-I was significantly lower at all concentrations than that obtained by apolipoprotein A-I. From linear regression analysis of kinetic data as shown in figure 1 app. V max is the reciprocal of the y-intercept; app. V max is the slope of the line; and app. K m is calculated from the other two quantities. The ratio app. V max /app. K m was significantly lower for glycated apolipoprotein (p < 0.01) using the Student's t-statistical test. Table 1 gives the results from the linear regression analysis of the kinetic data: correlation coefficients, apparent V max , apparent K m and app. V max /app. K m quantities. The app. V max /app. K m of glycated apolipoprotein A-I differs significantly from that of normal apolipoprotein A-I (p < 0.01).
Discussion
The present study indicates that glycated apolipoprotein A-I isolated from diabetic subjects is deficient in activating lecithin : cholesterol acyltransferase in vitro.
Information is very limited on the lecithin : cholesterol acyltransferase activity in the plasma of patients with diabetes mellitus. Fielding and coworkers (13) described decreased activity of lecithin : cholesterol acyltransferase in diabetics, whereas Schernthaner et al. (14) found normal activity. Gugliucci et al. (15) reported that 10 -15% glycation of lysine residues in apolipoprotein A-I produces a 40% decrease in lecithin : cholesterol acyltransferase activation, compared with the control. In the present study, differences in the reactivity of lecithin : cholesterol acyltransferase with glycated apolipoprotein A-I become measurable when the degree of glycation of lysine residues reached 3-5%.
An important consideration in studies of lecithin : cholesterol acyltransferase activity is the use of appropriate kinetic parameters to compare the reactivities of different substrates. In this report the ratio, apparent V max /apparent K m , was used to monitor the response of the enzyme to different substrates, after interaction of the enzyme with various concentrations of apolipoprotein A-I.
Studies using a series of native and synthetic fragments of apolipoprotein A-I support the concept that the interaction of the protein with lipids is of prime importance for this activating capacity of apolipoprotein A-I (11, 16, 17) . Lecithin : cholesterol acyltransferase does not require apolipoprotein to bind to lipid interfaces; however, on a pure lipid surface the active site may not be accessible to the lipid substrates (18) . When apolipoprotein is present, the access of substrates to the active site may be facilitated by a direct interaction of the enzyme with the protein cofactor, or by an activation of the lipid substrates via the protein cofactor. It is possible that the glycation of lysine may cause a disruption in the relationshipsŝ ome portions of the apolipoprotein A-I structure. Studies of lecithin : cholesterol acyltransferase activation by synthetic peptides have led to the proposal that the major lecithin : cholesterol acyltransferaseactivating domain of apolipoprotein A-I resides in the 22mer tandem repeats, located between residues 66 and 121 of the native apolipoprotein (19) . Therefore, additional studies will be required in order to identify the preferential site of non-enzymatic glycation in apolipoprotein A-I, and to establish whether this involves amino acid residues that are specifically required in lecithin : cholesterol acyltransferase activation.
The significance in vivo of this decreased lecithin : cholesterol acyltransferase activation by glycated apolipoprotein A-I remains to be established. Because lecithin: cholesterol acyltransferase provides a driving force in reverse cholesterol transport by esterifying the cellular cholesterol removed by high density lipoproteins, it is possible that this abnormal activation may be associated with a reduction in reverse choles-t erol transport and with the accelerated development of atherosclerosis in patients with diabetes mellitus.
